Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,099,075
+$6,797,703 QoQ
Shares Held
821,958
+173.2% QoQ
Ownership
0.872%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 199 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,865,295
PutShares
168,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. REPL ranks #122 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in REPL
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,865,295 | 168,500 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $9,099,075 | 821,958 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,301,372 | 300,833 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $574,515 | 75,100 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $822,375 | 107,500 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $8,111,942 | 834,562 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $1,458,000 | 150,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $1,257,000 | 300,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $6,661,031 | 1,589,745 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,376,761 | 794,054 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $3,833,983 | 412,700 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $696,750 | 75,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $11,926,551 | 1,223,236 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,406,806 | 1,189,662 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,656,838 | 1,154,821 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $28,062,315 | 3,118,035 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,773,412 | 461,862 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $126,669 | 15,026 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $233,568 | 13,651 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,377,931 | 403,873 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,383,391 | 587,961 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,493,491 | 275,496 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,385,211 | 138,113 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,782,365 | 101,966 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $225,205 | 13,263 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,813,684 | 103,826 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,621,124 | 88,432 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,594,417 | 119,584 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,923,529 | 95,822 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,189,431 | 214,664 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $254,278 | 11,046 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $594,231 | 59,602 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||